Idiopathic thrombocytopenic purpura induced by nivolumab in a metastatic melanoma patient with elevated PD-1 expression on B cells

Annals of Oncology

Volumn 27, Issue 3, 2016, Pages 546-547

  Kanameishi, S ^a   Otsuka, A ^a   Nonomura, Y ^a   Fujisawa, A ^a   Endo, Y ^a   Kabashima, K ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; NIVOLUMAB; PREDNISOLONE; PROGRAMMED DEATH 1 RECEPTOR; ROMIPLOSTIM; ANTINEOPLASTIC AGENT; FC RECEPTOR; HYBRID PROTEIN; MONOCLONAL ANTIBODY; PDCD1 PROTEIN, HUMAN; THROMBOPOIETIN;

AGED; ARTICLE; B LYMPHOCYTE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CASE REPORT; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOGENESIS; LUNG METASTASIS; LYMPH NODE DISSECTION; METASTATIC MELANOMA; ORAL BLEEDING; OVERALL SURVIVAL; PATIENT REFERRAL; PETECHIA; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; FEMALE; LUNG NEOPLASMS; MELANOMA; METABOLISM; PATHOLOGY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SECONDARY;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUNG NEOPLASMS; MELANOMA; PLATELET TRANSFUSION; PREDNISOLONE; PROGRAMMED CELL DEATH 1 RECEPTOR; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; THROMBOPOIETIN;

EID: 84959916365     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv580     Document Type: Letter

References (5)

1. Robert C, Long GV, Brady B et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 2015; 372: 320-330.
2. Naidoo J, Page DB, Li BT et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 2015; 26: 2375-2391.
3. Ghanima W, Khelif A, Waage A et al. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2015; 385: 1653-1661.
4. Nishimura H, Minato N, Nakano T et al. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 1998; 10: 1563-1572.
5. Yoshida T, Jiang F, Honjo T et al. PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice. Proc Natl Acad Sci USA 2008; 105: 3533-3538